Arca
Skip to content
Tools
Tools

CalcShift™ Displacement Calcaneal Osteotomy System

Plate, Fixation, Bone. 510(k) K212979, from Nextremity Solutions, Inc. (Warsaw, IN). Product code HRS, class 2.

As of Nov 18, 2026, K212979 is an FDA 510(k) held by Nextremity Solutions, Inc., substantially equivalent on May 20, 2022 after 245 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: May 20, 2022
  • Review time: 245 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Nextremity Solutions CalcShift™ Displacement Calcaneal Osteotomy System is indicated for osteotomies, non-unions, malunions, revisions, fusions, and reconstruction of the calcaneus requiring a medial or lateral displacement osteotomy.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other HRS Clearances

The newest 510(k)s for the same product code; their median review was 79 days; see every HRS device

Record

Type
Traditional
Received
Sep 17, 2021
Review panel
Orthopedic
Regulation
21 CFR 888.3030

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.